Status:
AVAILABLE
Expanded Access to Telisotuzumab Vedotin
Lead Sponsor:
AbbVie
Conditions:
Non-Small Cell Lung Cancer (NSCLC)
Eligibility:
18+ years
Brief Summary
This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Telisotuzumab vedotin prior to approval by the local regulatory agency. Availability w...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- The participant must not be eligible for a telisotuzumab vedotin clinical trial.
Exclusion
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04830202
Last Update
October 3 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.